Streetbeat News

Stock Prices

INM

InMed Pharmaceuticals announced that its Phase 2 clinical trial for INM-755 CBN cream, a treatment for symptoms related to epidermolysis bullosa, showed non-statistically significant results for non-wound itch.

Portfolio Pulse from Benzinga Newsdesk

June 22, 2023 | 6:25 pm

SRPT

Sarepta Therapeutics' shares resumed trading and moved lower.

Portfolio Pulse from Benzinga Newsdesk

June 22, 2023 | 6:20 pm

SLB

Unusual options activity has been detected for Schlumberger Limited (NYSE:SLB), with 10 strange trades observed. 50% of investors opened trades with bullish expectations, while the other 50% had bearish expectations. Whales have been targeting a price range of $35 to $50 for SLB over the last 3 months.

Portfolio Pulse from Benzinga Insights

June 22, 2023 | 6:17 pm

TSLA

Two camouflaged Tesla Cybertrucks were spotted in California, raising speculation about the potential start of production. Tesla aims to start production in summer 2023, with a ramp-up in the following year.

Portfolio Pulse from Benzinga EV Insights

June 22, 2023 | 6:15 pm

SRPT

Sarepta Therapeutics shares will resume trading at 2:20 p.m.

Portfolio Pulse from Benzinga Newsdesk

June 22, 2023 | 6:10 pm

ORAN

PANW

Palo Alto Networks (PANW) shares are trading higher after the company partnered with Orange Business and Orange Cyberdefense (ORAN) to offer a managed Secure Access Service Edge (SASE) solution for enterprise customers. BTIG analyst Gray Powell maintained a Buy rating for PANW and raised the price target from $253 to $307.

Portfolio Pulse from Ryan Gustafson

June 22, 2023 | 6:09 pm

CRNC

Cerence Inc (CRNC) shares are down 12.3% after pricing a $190 million offering of convertible senior notes due 2028. The company estimates net proceeds of approximately $184.1 million, which will be used for various purposes including repurchasing its 2025 notes and repayment of its term loan facility.

Portfolio Pulse from Henry Khederian

June 22, 2023 | 6:05 pm

SM

Susquehanna analyst Biju Perincheril reiterated a Neutral rating on SM Energy Company (NYSE:SM) and raised the price target to $32 from $30. The company is expected to benefit from Austin Chalk exploration results, increased capital return, and improved operating costs. SM Energy recently added 20,000 acres in the Northern Midland Basin, targeting the Dean and Middle Spraberry sand intervals.

Portfolio Pulse from Nabaparna Bhattacharya

June 22, 2023 | 6:04 pm

UCAR

U Power shares are trading lower following Wednesday's strength, indicating a pullback in the stock.

Portfolio Pulse from Benzinga Newsdesk

June 22, 2023 | 6:02 pm

ACCD

In the last quarter, Accolade (NASDAQ:ACCD) received 12 analyst ratings, with an average 12-month price target of $15.25, a high of $18.00, and a low of $13.00. The average price target increased by 20.65% over the past month.

Portfolio Pulse from Benzinga Insights

June 22, 2023 | 6:01 pm